Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Data Collective IV GP, LLC

Q3 2023 · 13F-HR

Data Collective IV GP, LLCholdings as filed

Filed 2023-11-14 · accession 0001104659-23-117593

$105.7M
Reported value
5
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
30049H102EVLVEvolv Technologies Holdings, Inc.$47.1M44.5%9,681,280CommonSOLE
75629V104RXRXRecursion Pharmaceuticals, Inc.$45.4M43.0%5,941,120CommonSOLE
773122106Rocket Lab USA, Inc.$12.8M12.1%2,929,350CommonSOLE
60255C885BRD1EURMind Medicine (MindMed) Inc.$314,0950.30%100,349CommonSOLE
G76279101ROIVRoivant Sciences Ltd.$45,2600.04%3,875CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.